Cristina Camara-La

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration.

Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration.

Journal: Molecular therapy. Advances

Published: October 08, 2025

Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates.

Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates.

Journal: Molecular therapy. Advances

Published: July 31, 2025

A hypomorphic variant of choroideremia is associated with a novel intronic mutation that leads to exon skipping.

A hypomorphic variant of choroideremia is associated with a novel intronic mutation that leads to exon skipping.

Journal: Ophthalmic genetics

Published: January 26, 2024

Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center.

Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center.

Journal: Biomolecules

Published: August 16, 2023

Developmental Expression of the Cell Cycle Regulator p16INK4a in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?

Developmental Expression of the Cell Cycle Regulator p16INK4a in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society

Published: June 23, 2023

Is RPGR-related retinal dystrophy associated with systemic disease? A case series.

Is RPGR-related retinal dystrophy associated with systemic disease? A case series.

Journal: Ophthalmic genetics

Published: January 05, 2023

Response: 'letter to the editor: emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa'.

Response: 'letter to the editor: emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa'.

Journal: Expert opinion on emerging drugs

Published: December 23, 2022

Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.

Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.

Journal: Expert opinion on emerging drugs

Published: December 23, 2022

Impaired glutamylation of RPGRORF15 underlies the cone-dominated phenotype associated with truncating distal ORF15 variants.

Impaired glutamylation of RPGRORF15 underlies the cone-dominated phenotype associated with truncating distal ORF15 variants.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 29, 2022

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina.

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina.

Journal: Molecular therapy. Methods & clinical development

Published: March 03, 2021

Accurate Quantification of AAV Vector Genomes by Quantitative PCR.

Accurate Quantification of AAV Vector Genomes by Quantitative PCR.

Journal: Genes

Published: February 22, 2021

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.

Journal: Nature communications

Published: June 24, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026